MedBodh Clinical Drug Preparation | Updated 4 November 2026. Professional reference; verify local brand-specific prescribing information and hospital protocol before bedside administration.
CLINICAL SAFETY NOTICE (5 Nov 2026): Educational overview only, not a validated bedside preparation chart. Verify exact dose, dilution, rate, compatibility, stability, renal/hepatic adjustments and paediatric use against the specific product label, current institutional protocol and pharmacist. Do not infer dosing from this page alone.
Clinical indications and strengths
Calcium gluconate injection 10% contains 100 mg/mL calcium gluconate, corresponding to about 9.3 mg/mL elemental calcium. The manufacturer label recommends dilution in 5% dextrose or normal saline before IV administration. For labelled bolus administration, the final concentration is 10–50 mg/mL and the maximum administration rate is 200 mg/min in adults or 100 mg/min in children; the indication and prescribed dose must still be checked.
Preparation and administration workflow
- Verify patient identity, indication, allergy history, body weight where applicable and prescriber’s order.
- Read actual vial/bag concentration and distinguish salt strength from active-base equivalent where relevant.
- Check manufacturer-authorised diluent, final concentration, compatibility, route, infusion pump and beyond-use time.
- Perform independent high-alert medication double-check and label every prepared syringe/bag.
- Document preparation, administration, monitoring and any adverse reaction.
Emergency safety, nursing monitoring and special populations
Indication in the cited label: acute symptomatic hypocalcaemia; other emergency uses such as ECG changes in hyperkalaemia follow separate local protocols and do not replace potassium-lowering treatment. Monitor ECG, BP, ionized/serum calcium and IV-site integrity. Rapid injection may cause bradycardia, hypotension or arrhythmia. Extravasation can cause calcinosis and tissue necrosis; stop at once if suspected. Check compatibility, especially phosphate- or bicarbonate-containing solutions, and renal impairment.
Adult and paediatric dosing
There is no single safe universal dose: dosing varies by indication, age/weight, organ function, formulation and clinical response. Use the linked full product label and the current hospital emergency algorithm rather than extrapolating one preparation to every scenario.
Contraindications, interactions and common errors
Review the product-specific label, comorbidities, concurrent medicines and IV compatibility. Do not mix drugs in the same line without verified compatibility. Escalate immediately for suspected medication error or adverse drug reaction.
Primary manufacturer label
DailyMed: current official product labelling. Indian brands can differ in concentration, excipients and authorised routes; verify the locally stocked ampoule.